GlassScriptPhysician profile
Norbert Csordas
NPI 1104488048
$4,170.39
in general payments reported to CMS, 2019-2025
19 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what 82% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $941 · 2022: $1,106 · 2023: $377 · 2024: $641 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,123.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,145.54 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $956.05 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $395.85 | 2021-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $383.20 | 2021-2025 | Trintellix |
| Sunovion Pharmaceuticals INC. | $227.30 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $226.67 | 2022-2024 | Ingrezza |
| Janssen Pharmaceuticals, INC | $205.76 | 2021-2025 | Spravato |
| Teva Pharmaceuticals USA, INC. | $119.25 | 2024 | Austedo Xr |
| Biogen, INC. | $105.89 | 2025 | Zurzuvae |
| Alkermes, INC. | $84.84 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $56.17 | 2021-2022 | |
| Lundbeck LLC | $53.92 | 2024-2025 | Rexulti |
| Owp Pharmaceuticals, INC. | $44.32 | 2022-2024 | Subvenite, Lamotrigine |
| Axsome Therapeutics, INC. | $41.93 | 2025 | Auvelity |
| Bausch Health US, LLC | $41.12 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $29.66 | 2022 | |
| Eisai INC. | $26.24 | 2021 | |
| Almatica Pharma LLC | $14.75 | 2022 | |
| Corium, LLC | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norbert Csordas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.